52 results
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
7 May 24
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering of Common Stock
5:28pm
or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems … proceedings relating to the Company’s or any Subsidiary’s information privacy or data security practices.
(jj) The Company and the Subsidiaries have
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
and contractual obligations relating to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from … Data. To the Company’s knowledge, no person has commenced any proceedings relating to the Company’s or any Subsidiary’s information privacy or data
424B5
SLNO
Soleno Therapeutics Inc
29 Sep 23
Prospectus supplement for primary offering
4:51pm
and market, sell and distribute any products for which we obtain marketing approval. In addition, we may be subject to transparency laws and patient privacy … obligations, including mandatory contractual terms, with respect to safeguarding the privacy, security and transmission of individually identifiable health
424B5
fjm925elycy3rixr
27 Sep 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-1.1
1nl984w6g8xjmzh8m9
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
424B5
oavm dxjdzgaefdl
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
9zxqq
28 Mar 22
Prospectus supplement for primary offering
4:53pm
8-K
EX-1.1
dj3mw3s9frkm51
16 Jul 21
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-1.1
8y865
26 Jun 20
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
4:31pm
424B5
6vj9bj02cwy kdge
25 Jun 20
Prospectus supplement for primary offering
4:01pm